CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 49 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $185,000 | -69.3% | 69,435 | -50.0% | 0.04% | -38.7% |
| Q4 2021 | $602,000 | +70.5% | 138,870 | +100.0% | 0.06% | -19.5% |
| Q3 2021 | $353,000 | -51.8% | 69,435 | -40.0% | 0.08% | -41.7% |
| Q2 2021 | $733,000 | -18.0% | 115,768 | +0.1% | 0.13% | -19.0% |
| Q1 2021 | $894,000 | +96.5% | 115,647 | +66.6% | 0.16% | +68.0% |
| Q4 2020 | $455,000 | -1.5% | 69,435 | 0.0% | 0.10% | -20.5% |
| Q3 2020 | $462,000 | -20.1% | 69,435 | 0.0% | 0.12% | -17.0% |
| Q2 2020 | $578,000 | -24.0% | 69,435 | +17.7% | 0.15% | -27.9% |
| Q1 2016 | $761,000 | – | 59,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |